Previous 10 | Next 10 |
home / stock / evo / evo articles
German drug developer Evotec SE (NASDAQ:EVO) is reportedly consulting defense advisers following a significant drop in share price, raising concern...
Shares of Ovid Therapeutics Inc (NASDAQ:OVID) dipped 65.7% to $1.1285 after Takeda’s Skyline study in Dravet syndrome missed its primary endp...
Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX) rose sharply in today's pre-market trading after the company announced results from its ongoi...
U.S. stocks traded slightly lower toward the end of trading, with the S&P 500 edging lower on Wednesday. The Dow traded down 0.18% to 38,434.99...
U.S. stocks traded mixed midway through trading, with the Dow Jones falling over 100 points on Wednesday. The Dow traded down 0.33% to 38,376.53 wh...
U.S. stocks traded mixed this morning, with the Nasdaq Composite gaining around 0.5% on Wednesday. Following the market opening Wednesday, the Dow ...
European life science company Evotec SE (NASDAQ:EVO) announced a priority reset to optimize its business to meet evolving marke...
Shares of Tesla, Inc. (NASDAQ:TSLA) rose sharply in today's pre-market trading following first-quarter results. Tesla posted weaker-than-expec...
U.S. stock futures were mixed this morning, with the Nasdaq futures gaining over 70 points on Wednesday. Shares of Enphase Energy, Inc. (NASDAQ:ENP...
News, Short Squeeze, Breakout and More Instantly...
Just - Evotec Biologics will deliver an ultra-rapid, cost-efficient biotherapeutics manufacturing platform solution for the DOD's Manufacturing Optimization Program Manufacturing solution includes seamless integration of accelerated mAb drug development into the overall Manufacturing Optimiz...
Key scientific achievement advances the joint pipeline in the strategic neuroscience partnership with Bristol Myers Squibb and earns a payment of US$ 20 m to Evotec to progress further research HAMBURG, GERMANY / ACCESSWIRE / June 12, 2024 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/T...
Most agenda items adopted with great majority Annual General Meeting 2024 elects Dr Duncan McHale and Wesley Wheeler to the Supervisory Board, replacing Dr Elaine Sullivan and Dr Mario Polywka HAMBURG, GERMANY / ACCESSWIRE / June 10, 2024 / Evotec SE (Frankfurt Stock Exchange:EVT)(MDA...